AIDS Malignancy Consortium
-
Inovio, Plymouth Meeting, enters partnership for immunotherapy study
Inovio Pharmaceuticals, Inc. has entered into a partnership with the AIDS Malignancy Consortium to evaluate VGX-3100 as a potential therapy…
AIDS Malignancy Consortium

Inovio Pharmaceuticals, Inc. has entered into a partnership with the AIDS Malignancy Consortium to evaluate VGX-3100 as a potential therapy…